Systematic review of the values and preferences regarding the use of injectable pre‐exposure prophylaxis to prevent HIV acquisition
L Lorenzetti, N Dinh, A van der Straten… - Journal of the …, 2023 - Wiley Online Library
Abstract Introduction Pre‐exposure prophylaxis (PrEP) is an important HIV prevention
option. Two randomized trials have provided efficacy evidence for long‐acting injectable …
option. Two randomized trials have provided efficacy evidence for long‐acting injectable …
Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trials
Adherence is a critical component of the success of antiretroviral-based pre-exposure
prophylaxis (PrEP) in averting new HIV-infections. Ensuring drug availability at the time of …
prophylaxis (PrEP) in averting new HIV-infections. Ensuring drug availability at the time of …
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men
RM Grant, JR Lama, PL Anderson… - … England Journal of …, 2010 - Mass Medical Soc
Background Antiretroviral chemoprophylaxis before exposure is a promising approach for
the prevention of human immunodeficiency virus (HIV) acquisition. Methods We randomly …
the prevention of human immunodeficiency virus (HIV) acquisition. Methods We randomly …
Pharmacokinetics of long-acting tenofovir alafenamide (GS-7340) subdermal implant for HIV prophylaxis
M Gunawardana, M Remedios-Chan… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Oral or topical daily administration of antiretroviral (ARV) drugs to HIV-1-negative individuals
in vulnerable populations is a promising strategy for HIV-1 prevention. Adherence to the …
in vulnerable populations is a promising strategy for HIV-1 prevention. Adherence to the …
Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE‐C qualitative study in Johannesburg, South Africa
A Van Der Straten, J Stadler, E Luecke… - Journal of the …, 2014 - Wiley Online Library
Introduction Antiretroviral (ARV)‐based pre‐exposure prophylaxis (PrEP) is a promising new
HIV prevention strategy. However, variable levels of adherence have yielded mixed results …
HIV prevention strategy. However, variable levels of adherence have yielded mixed results …
Helping our patients take HIV pre‐exposure prophylaxis (PrEP): a systematic review of adherence interventions
Objectives Adherence is critical for maximizing the effectiveness of pre‐exposure
prophylaxis (PrEP) in preventing HIV infection. Strategies for promoting adherence to HIV …
prophylaxis (PrEP) in preventing HIV infection. Strategies for promoting adherence to HIV …
Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction
M Lanham, R Wilcher, ET Montgomery… - Journal of the …, 2014 - Wiley Online Library
Introduction Constructively engaging male partners in women‐centred health programs
such as family planning and prevention of mother‐to‐child HIV transmission has resulted in …
such as family planning and prevention of mother‐to‐child HIV transmission has resulted in …
Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men: perspectives of PrEP users and high-risk PrEP naive men
Existing trials of antiretroviral (ARV) medication as chemoprophylaxis against HIV reveal that
the degree of protection is primarily dependent on product adherence. However, there is a …
the degree of protection is primarily dependent on product adherence. However, there is a …
Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study
A Liu, DV Glidden, PL Anderson… - JAIDS Journal of …, 2014 - journals.lww.com
Background: Adherence to pre-exposure prophylaxis (PrEP) is critical for efficacy.
Antiretroviral concentrations are an objective measure of PrEP use and correlate with …
Antiretroviral concentrations are an objective measure of PrEP use and correlate with …
Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco
HJ Gilmore, A Liu, KA Koester, KR Amico… - AIDS Patient Care …, 2013 - liebertpub.com
In 2010, the iPrEx study demonstrated efficacy of daily emtricitabine/tenofovir disoproxil
fumarate (FTC/TDF) pre-exposure prophylaxis (PrEP) in reducing HIV acquisition among …
fumarate (FTC/TDF) pre-exposure prophylaxis (PrEP) in reducing HIV acquisition among …